Peer-reviewed veterinary case report
Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.
- Journal:
- Journal of feline medicine and surgery
- Year:
- 2005
- Authors:
- Pu, Ruiyu et al.
- Affiliation:
- Department of Pathobiology · United States
- Species:
- cat
Plain-English summary
Researchers tested a vaccine called Fel-O-Vax FIV, which is designed to protect cats from two types of feline immunodeficiency virus (FIV), to see if it also works against a different type known as subtype B. This subtype B is the most common form of FIV found in the United States. The results showed that the Fel-O-Vax FIV vaccine is effective in protecting against this subtype B virus.
Abstract
Vaccine trials were undertaken to determine whether the Fel-O-Vax FIV, a commercial dual-subtype (subtypes A and D) feline immunodeficiency virus (FIV) vaccine, is effective against a subtype B FIV isolate. Current results demonstrate the Fel-O-Vax FIV to be effective against a subtype B virus, a subtype reported to be the most common in the USA.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/15686976/